Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$elut](/topic/$elut)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$elut/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$elut/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XX% -XX%  
**1-Year High**: XXX% on 2025-06-26  
**1-Year Low**: XX% on 2025-08-25  

**Most Supportive Themes**
- **BioEnvelope Business Sale:** (60%) Elutia's sale of its BioEnvelope business to Boston Scientific for $XX million is a key positive development.
- **Focus on Breast Reconstruction:** (20%) The deal allows Elutia to focus on breast reconstruction and drug-eluting pipelines.
  
**Most Critical Themes**
- **General Market Sentiment:** (10%)  While sentiment is currently positive, the lack of specific details on future product performance could be a concern.
- **Engagement Decline:** (10%)  Despite positive news, the decline in engagements and mentions could indicate a lack of sustained interest.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %    | Negative | %  |
| ------- | -------- | -  | ------- | -    | -------- | -  |
| X       | X        | X% | XX      | XXX% | X        | X% |
|         |          |    |         |      |          |    |
| Total   | X        | X% | XX      | XXX% | X        | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$elut

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -XX%
1-Year High: XXX% on 2025-06-26
1-Year Low: XX% on 2025-08-25

Most Supportive Themes

  • BioEnvelope Business Sale: (60%) Elutia's sale of its BioEnvelope business to Boston Scientific for $XX million is a key positive development.
  • Focus on Breast Reconstruction: (20%) The deal allows Elutia to focus on breast reconstruction and drug-eluting pipelines.

Most Critical Themes

  • General Market Sentiment: (10%) While sentiment is currently positive, the lack of specific details on future product performance could be a concern.
  • Engagement Decline: (10%) Despite positive news, the decline in engagements and mentions could indicate a lack of sustained interest.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X X X% XX XXX% X X%
Total X X% XX XXX% X X%
$elut Sentiment
/topic/$elut/sentiment